CyberKnife® for Brain Tumors

CyberKnife robotic stereotactic radiosurgery (SRS) painlessly delivers precise beams of high-dose radiation to brain tumors and lesions, without incisions, hospitalization, or long recovery time. CyberKnife SRS is a non-invasive alternative to brain cancer surgery and can be used for brain tumors that are considered inoperable because of their location in the head, for those patients who cannot undergo brain cancer surgery due to their poor medical condition, or who refuse surgery. The CyberKnife System also can treat benign, or non-cancerous, tumors and other conditions, such as trigeminal neuralgia and arteriovenous malformations (AVMs).

BRAIN CANCER BEFORE AND AFTER TREATMENT WITH CYBERKNIFE

Pre-Treatment

Post-Treatment

82 year old female treated for breast cancer in 2007 and 2012. Follow-up in 2012 she presented with brain metastasis in the right frontal and left occipital parietal lobes and was treated with SRS. The patient developed an additional metastases in her left occipital lobe in 2013, also treated with SRS. The patient then went on to develop subsequent metastases in the right temporal and the left medial cerebellum in February and March of 2014. These new lesions again received SRS treatment. The MRI used for this most recent treatment plan showed the 2 previously treated frontal lesions completely resolved.

Brain Tumor Types

  • Acoustic Neuroma
  • Anaplastic Astrocytoma
  • Brain Metastases
  • Chordoma
  • Craniopharyngioma
  • Ependymoma
  • Gangliocytoma
  • Germinoma
  • Glioblastoma Multiforme
  • Glioma
  • Glomus Tumors
  • Hemangioblastoma
  • Meningioma
  • Neurocytoma
  • Neurofibroma
  • Neurofibromatosis
  • Oligodendroglioma
  • Parotid SCCA
  • Pituitary Adenoma
  • Schwannoma
  • Skull Base Tumors
  • Vestibular Schwannoma

Key Advantages of CyberKnife for Brain Tumors

  • Non-invasive, no incisions, painless
  • No anesthesia or hospitalization required
  • Treats patients in 5 or fewer visits
  • Reaches tumors from virtually unlimited directions with robotic mobility
  • Enables clinicians to maximize and conform the dose to the tumor target
  • Constantly tracks tumor movement throughout treatment
  • Pinpoint Accuracy
  • Few side effects and minimal radiation exposure to healthy tissue surrounding the tumor
  • Immediate return to daily activities

Patient Resource Tools

Related News

Speak with one of our dedicated team members about how we can help today.

Follow Us